Moderna Signs Deal on Variant-Adapted COVID Shots for World’s Poorest

A bottle containing the new Moderna Spikevax mRNA COVID 19 vaccine stands ready to be drawn into syringes at the centre of the Geneva University Hospitals (HUG), that opened for the public to get the forth booster dose againt COVID, in Geneva, Switzerland, 10 October 2022. (EPA)

Moderna Inc has agreed to provide its new variant-adapted COVID-19 vaccine to the global scheme aiming to deliver shots to the world's poorest people.

The biotech company and vaccine alliance GAVI will cancel their existing supply deal for vaccines based on the original coronavirus strain. Instead, Moderna will supply up to 100 million doses of its new, variant-adapted vaccines at its lowest available price from 2023.